The Korean Journal of Pain

The Korean Pain Society (대한통증학회)
권호 표지
DOI QR코드

DOI QR Code

Inflammatory cytokines in midbrain periaqueductal gray contribute to diabetic induced pain hypersensitivity through phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway

  • Guo, Mochi (Department of Anesthesia, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University School of Medicine)) ;
  • Jiang, Zongming (Department of Anesthesia, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University School of Medicine)) ;
  • Chen, Yonghao (Department of Anesthesia, Kowloon Hospital, Shanghai Jiaotong University School of Medicine) ;
  • Wang, Fei (Bioinformation Branch, Hangzhou Hibio Bioinformation Technology Company Hang Zhou) ;
  • Wang, Zhifeng (Department of Anesthesia, Shaoxing Second Hospital)
  • Received : 2020.11.09
  • Accepted : 2020.12.24
  • Published : 2021.04.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Diabetes-related neuropathic pain frequently occurs, and the underpinning mechanism remains elusive. The periaqueductal gray (PAG) exhibits descending inhibitory effects on central pain transmission. The current work aimed to examine whether inflammatory cytokines regulate mechanical allodynia and thermal hyperalgesia induced by diabetes through the phosphoinositide 3-kinase (PI3K)-mammalian target of rapamycin (mTOR) pathway in the PAG. Methods: Streptozotocin (STZ) was administered intraperitoneally to mimic allodynia and hyperalgesia evoked by diabetes in rats. Behavioral assays were carried out for determining mechanical pain and thermal hypersensitivity. Immunoblot and ELISA were performed to examine PAG protein amounts of interleukin-1β (IL-1β), IL-6, and tumor necrosis factor-α (TNF-α), as well as their corresponding receptors in STZ rats, and the expression of PI3K/protein kinase B (Akt)/mTOR signaling effectors. Results: Increased PAG p-PI3K/p-Akt/p-mTOR protein amounts were observed in STZ-induced animals, a PI3K-mTOR pathway inhibition in the PAG attenuated neuropathic pain responses. Moreover, the PAG concentrations of IL-1β, IL-6, and TNF-α and their receptors (namely, IL-1R, IL-6R, and tumor necrosis factor receptor [TNFR] subtype TNFR1, respectively) were increased in the STZ rats. Additionally, inhibiting IL-1R, IL-6R, and TNFR1 ameliorated mechanical allodynia and thermal hyperalgesia in STZ rats, alongside the downregulation of PI3K-mTOR signaling. Conclusions: Overall, the current study suggests that upregulated proinflammatory cytokines and their receptors in the PAG activate PI3K-mTOR signaling, thereby producing a de-inhibition effect on descending pathways in modulating pain transmission, and eventually contributing to neuropathic pain.

Keywords

References

  1. Vinik AI. Clinical practice. Diabetic sensory and motor neuropathy. N Engl J Med 2016; 374: 1455-64. https://doi.org/10.1056/NEJMcp1503948
  2. Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med 2017; 376: 2367-75. https://doi.org/10.1056/NEJMra1615439
  3. Ji RR, Nackley A, Huh Y, Terrando N, Maixner W. Neuroinflammation and central sensitization in chronic and widespread pain. Anesthesiology 2018; 129: 343-66. https://doi.org/10.1097/ALN.0000000000002130
  4. Morgado C, Terra PP, Tavares I. Neuronal hyperactivity at the spinal cord and periaqueductal grey during painful diabetic neuropathy: effects of gabapentin. Eur J Pain 2010; 14: 693-9. https://doi.org/10.1016/j.ejpain.2009.11.011
  5. Morgado C, Silva L, Pereira-Terra P, Tavares I. Changes in serotoninergic and noradrenergic descending pain pathways during painful diabetic neuropathy: the preventive action of IGF1. Neurobiol Dis 2011; 43: 275-84. https://doi.org/10.1016/j.nbd.2011.04.001
  6. Lisi L, Aceto P, Navarra P, Dello Russo C. mTOR kinase: a possible pharmacological target in the management of chronic pain. Biomed Res Int 2015; 2015: 394257.
  7. Santini E, Huynh TN, Klann E. Mechanisms of translation control underlying long-lasting synaptic plasticity and the consolidation of long-term memory. Prog Mol Biol Transl Sci 2014; 122: 131-67. https://doi.org/10.1016/B978-0-12-420170-5.00005-2
  8. Guo JR, Wang H, Jin XJ, Jia DL, Zhou X, Tao Q. Effect and mechanism of inhibition of PI3K/Akt/mTOR signal pathway on chronic neuropathic pain and spinal microglia in a rat model of chronic constriction injury. Oncotarget 2017; 8: 52923-34. https://doi.org/10.18632/oncotarget.17629
  9. Price TJ, Rashid MH, Millecamps M, Sanoja R, Entrena JM, Cervero F. Decreased nociceptive sensitization in mice lacking the fragile X mental retardation protein: role of mGluR1/5 and mTOR. J Neurosci 2007; 27: 13958-67. https://doi.org/10.1523/JNEUROSCI.4383-07.2007
  10. Xu Q, Fitzsimmons B, Steinauer J, O'Neill A, Newton AC, Hua XY, et al. Spinal phosphinositide 3-kinase-Akt-mammalian target of rapamycin signaling cascades in inflammation-induced hyperalgesia. J Neurosci 2011; 31: 2113-24. https://doi.org/10.1523/JNEUROSCI.2139-10.2011
  11. Asante CO, Wallace VC, Dickenson AH. Formalin-induced behavioural hypersensitivity and neuronal hyperexcitability are mediated by rapid protein synthesis at the spinal level. Mol Pain 2009; 5: 27. https://doi.org/10.1186/1744-8069-5-27
  12. Zeng H, Chi H. mTOR signaling in the differentiation and function of regulatory and effector T cells. Curr Opin Immunol 2017; 46: 103-11. https://doi.org/10.1016/j.coi.2017.04.005
  13. Li JN, Sheets PL. The central amygdala to periaqueductal gray pathway comprises intrinsically distinct neurons differentially affected in a model of inflammatory pain. J Physiol 2018; 596: 6289-305. https://doi.org/10.1113/jp276935
  14. Mills EP, Di Pietro F, Alshelh Z, Peck CC, Murray GM, Vickers ER, et al. Brainstem pain-control circuitry connectivity in chronic neuropathic pain. J Neurosci 2018; 38: 465-73. https://doi.org/10.1523/JNEUROSCI.1647-17.2017
  15. Ong WY, Stohler CS, Herr DR. Role of the prefrontal cortex in pain processing. Mol Neurobiol 2019; 56: 1137-66. https://doi.org/10.1007/s12035-018-1130-9
  16. Shabab T, Khanabdali R, Moghadamtousi SZ, Kadir HA, Mohan G. Neuroinflammation pathways: a general review. Int J Neurosci 2017; 127: 624-33. https://doi.org/10.1080/00207454.2016.1212854
  17. Gwak YS, Hulsebosch CE, Leem JW. Neuronal-glial interactions maintain chronic neuropathic pain after spinal cord injury. Neural Plast 2017; 2017: 2480689. https://doi.org/10.1155/2017/2480689
  18. Yang Y, Zhang Z, Guan J, Liu J, Ma P, Gu K, et al. Administrations of thalidomide into the rostral ventromedial medulla alleviates painful diabetic neuropathy in Zucker diabetic fatty rats. Brain Res Bull 2016; 125: 144-51. https://doi.org/10.1016/j.brainresbull.2016.06.013
  19. Goyal SN, Reddy NM, Patil KR, Nakhate KT, Ojha S, Patil CR, et al. Challenges and issues with streptozotocin-induced diabetes - a clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics. Chem Biol Interact 2016; 244: 49-63. https://doi.org/10.1016/j.cbi.2015.11.032
  20. Swanson LW. Brain maps 4.0-structure of the rat brain: an open access atlas with global nervous system nomenclature ontology and flatmaps. J Comp Neurol 2018; 526: 935-43. https://doi.org/10.1002/cne.24381
  21. Um SW, Kim MJ, Leem JW, Bai SJ, Lee BH. Pain-relieving effects of mTOR inhibitor in the anterior cingulate cortex of neuropathic rats. Mol Neurobiol 2019; 56: 2482-94. https://doi.org/10.1007/s12035-018-1245-z
  22. Fischer TZ, Waxman SG. Neuropathic pain in diabetes--evidence for a central mechanism. Nat Rev Neurol 2010; 6: 462-6. https://doi.org/10.1038/nrneurol.2010.90
  23. Bogush M, Heldt NA, Persidsky Y. Blood brain barrier injury in diabetes: unrecognized effects on brain and cognition. J Neuroimmune Pharmacol 2017; 12: 593-601. https://doi.org/10.1007/s11481-017-9752-7
  24. Benarroch EE. Periaqueductal gray: an interface for behavioral control. Neurology 2012; 78: 210-7. https://doi.org/10.1212/WNL.0b013e31823fcdee
  25. Tortorici V, Morgan MM. Comparison of morphine and kainic acid microinjections into identical PAG sites on the activity of RVM neurons. J Neurophysiol 2002; 88: 1707-15. https://doi.org/10.1152/jn.2002.88.4.1707
  26. Guo J, Fu X, Cui X, Fan M. Contributions of purinergic P2X3 receptors within the midbrain periaqueductal gray to diabetes-induced neuropathic pain. J Physiol Sci 2015; 65: 99-104. https://doi.org/10.1007/s12576-014-0344-5
  27. Zhuang X, Chen Y, Zhuang X, Chen T, Xing T, Wang W, et al. Contribution of pro-inflammatory cytokine signaling within midbrain periaqueductal gray to pain sensitivity in Parkinson's disease via GABAergic pathway. Front Neurol 2016; 7:104. https://doi.org/10.3389/fneur.2016.00104
  28. Probert L. TNF and its receptors in the CNS: the essential, the desirable and the deleterious effects. Neuroscience 2015; 302: 2-22. https://doi.org/10.1016/j.neuroscience.2015.06.038
  29. Loggia ML, Chonde DB, Akeju O, Arabasz G, Catana C, Edwards RR, et al. Evidence for brain glial activation in chronic pain patients. Brain 2015; 138(Pt 3): 604-15. https://doi.org/10.1093/brain/awu377
  30. Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol 2014; 6: a016295. https://doi.org/10.1101/cshperspect.a016295
  31. Hoffman HM, Rosengren S, Boyle DL, Cho JY, Nayar J, Mueller JL, et al. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 2004; 364: 1779-85. https://doi.org/10.1016/S0140-6736(04)17401-1
  32. Oka T, Aou S, Hori T. Intracerebroventricular injection of interleukin-1 beta enhances nociceptive neuronal responses of the trigeminal nucleus caudalis in rats. Brain Res 1994; 656: 236-44. https://doi.org/10.1016/0006-8993(94)91466-4
  33. Hahm ET, Kim Y, Lee JJ, Cho YW. GABAergic synaptic response and its opioidergic modulation in periaqueductal gray neurons of rats with neuropathic pain. BMC Neurosci 2011; 12: 41. https://doi.org/10.1186/1471-2202-12-41
  34. Mahdian Dehkordi F, Kaboutari J, Zendehdel M, Javdani M. The antinociceptive effect of artemisinin on the inflammatory pain and role of GABAergic and opioidergic systems. Korean J Pain 2019; 32: 160-7. https://doi.org/10.3344/kjp.2019.32.3.160

Cited by

  1. Fluorocitrate and neurotropin confer analgesic effects on neuropathic pain in diabetic rats via inhibition of astrocyte activation in the periaqueductal gray vol.768, 2022, https://doi.org/10.1016/j.neulet.2021.136378